TC
BMY icon

Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Trust Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Sell
41,125
-4,343
-10% -$249K 0.21% 47
2026
Q1 		$2.76M Sell
45,468
-1,552
-3% -$90.5K 0.26% 41
2025
Q4 		$2.54M Buy
47,020
+7,872
+20% +$379K 0.24% 47
2025
Q3 		$1.77M Buy
39,148
+7,018
+22% +$328K 0.18% 49
2025
Q2 		$1.49M Buy
32,130
+23,365
+267% +$1.15M 0.17% 51
2025
Q1 		$535K Sell
8,765
-4,774
-35% -$278K 0.06% 88
2024
Q4 		$766K Buy
13,539
+1,556
+13% +$86.9K 0.09% 69
2024
Q3 		$620K Sell
11,983
-2,348
-16% -$110K 0.07% 75
2024
Q2 		$595K Sell
14,331
-4,517
-24% -$202K 0.08% 75
2024
Q1 		$1.02M Buy
18,848
+16,031
+569% +$817K 0.13% 57
2023
Q4 		$145K Sell
2,817
-872
-24% -$45.8K 0.02% 136
2023
Q3 		$214K Sell
3,689
-5,096
-58% -$312K 0.03% 122
2023
Q2 		$562K Sell
8,785
-252
-3% -$16.9K 0.08% 76
2023
Q1 		$626K Sell
9,037
-123
-1% -$8.68K 0.1% 78
2022
Q4 		$659K Sell
9,160
-46
-0.5% -$3.47K 0.11% 78
2022
Q3 		$654K Buy
9,206
+78
+0.9% +$5.66K 0.14% 72
2022
Q2 		$703K Sell
9,128
-12,461
-58% -$949K 0.15% 67
2022
Q1 		$1.58M Sell
21,589
-2,037
-9% -$137K 0.31% 35
2021
Q4 		$1.47M Buy
23,626
+769
+3% +$45.1K 0.34% 34
2021
Q3 		$1.35M Buy
22,857
+5,821
+34% +$383K 0.35% 33
2021
Q2 		$1.14M Sell
17,036
-257
-1% -$16.8K 0.8% 37
2021
Q1 		$1.09M Buy
17,293
+117
+0.7% +$7.28K 0.79% 34
2020
Q4 		$1.06M Sell
17,176
-3,333
-16% -$205K 0.84% 30
2020
Q3 		$1.24M Sell
20,509
-412
-2% -$24.8K 1.04% 23
2020
Q2 		$1.23M Buy
20,921
+2,885
+16% +$173K 1.17% 21
2020
Q1 		$1M Sell
18,036
-1,186
-6% -$72.5K 1.11% 25
2019
Q4 		$1.23M Buy
19,222
+111
+0.6% +$6.36K 1.08% 26
2019
Q3 		$969K Sell
19,111
-3,166
-14% -$149K 0.92% 35
2019
Q2 		$1.01M Sell
22,277
-52,638
-70% -$2.45M 0.93% 35
2019
Q1 		$3.57M Sell
74,915
-10,938
-13% -$545K 2.08% 13
2018
Q4 		$4.46M Buy
85,853
+82,653
+2,583% +$4.44M 2.48% 16
2018
Q3 		$199K Hold
3,200
– – 0.09% 78
2018
Q2 		$177K Hold
3,200
– – 0.08% 87
2018
Q1 		$202K Sell
3,200
-334
-9% -$21.5K 0.07% 83
2017
Q4 		$217K Buy
3,534
+1,000
+39% +$62.5K 0.09% 73
2017
Q3 		$162K Buy
2,534
+309
+14% +$18K 0.09% 77
2017
Q2 		$124K Sell
2,225
-155
-7% -$8.44K 0.06% 108
2017
Q1 		$129K Hold
2,380
– – 0.06% 120
2016
Q4 		$139K Buy
2,380
+100
+4% +$5.47K 0.07% 113
2016
Q3 		$123K Buy
2,280
+400
+21% +$25.7K 0.05% 128
2016
Q2 		$138K Hold
1,880
– – 0.05% 124
2016
Q1 		$120K Sell
1,880
-69
-4% -$4.35K 0.05% 127
2015
Q4 		$134K Sell
1,949
-5,140
-73% -$340K 0.06% 108
2015
Q3 		$420K Sell
7,089
-2,660
-27% -$169K 0.24% 69
2015
Q2 		$649K Hold
9,749
– – 0.41% 70
2015
Q1 		$629K Buy
+9,749
New +$610K 0.4% 78

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Trust Company's BMY Position: Q2 2026 in Review

Trust Company reduced its Bristol-Myers Squibb (BMY) stake by 9.6% in Q2 2026, selling an estimated $249K and leaving 41,125 shares worth $2.37M. The position accounts for 0.21% of the portfolio, ranked #47.

Trust Company first reported a position in BMY in Q1 2015 and has held it in 46 quarters since. The position peaked at $4.46M in Q4 2018. 502 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Trust Company held 41,125 shares of Bristol-Myers Squibb worth $2.37M as of Q2 2026.
  • Trust Company sold 4,343 Bristol-Myers Squibb shares in Q2 2026, an estimated $249K.
  • Bristol-Myers Squibb made up 0.21% of Trust Company's portfolio in Q2 2026, its #47 holding.
  • Trust Company first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 46 quarters since.
  • Trust Company's Bristol-Myers Squibb position peaked at $4.46M in Q4 2018.
  • 502 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.